通威股份(600438.SH):國壽資產減持通威轉債500萬張
格隆匯2月26日丨通威股份(600438.SH)公佈,2020年2月26日,公司接到債券持有人中國人壽資產管理有限公司(以下簡稱“國壽資產”)通知,國壽資產及其一致行動人於2019年5月7日至2020年2月26日期間通過二級市場合計減持通威轉債500萬張,佔通威轉債發行總量的10%。
本次累計減持後,國壽資產及其一致行動人仍合計持有通威轉債653.361萬張,佔通威轉債發行總量的13.07%,佔尚未轉股的通威轉債數量(以截止到2019年12月31日尚未轉股的轉債數量為基數)的13.07%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.